Nektar Therapeutics
Nektar Therapeutics (NKTR) — Form 8-K: Current report
About this filing
Nektar Therapeutics (NKTR) filed an 8-K on Oct 1, 2026 reporting a Regulation FD disclosure (Item 7.01), with exhibits (Item 9.01).
Key facts
- Item 7.01 · Regulation FD disclosure
- Item 9.01 · Financial statements and exhibits
More NKTR filings
- S-8
Filed Oct 19, 2026
- SC 13G/A
Filed Sep 28, 2026
- 4
Filed Sep 25, 2026
- 4
Filed Sep 25, 2026
- 4
Filed Sep 25, 2026
- 4
Filed Sep 25, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.